Using cell lineage markers, the researchers identified a novel COL6A5/18A1+ fibroblast subset uniquely distributed in the AD lesions, associated with a higher release of the CCL2, CCL19, and IL-32 (25). Here, CCL2 is linked to Alzheimer disease.